Introduction
============

No evaluation of a patient either suspected or diagnosed with MS is complete without a systematic examination of their vision and eye movements ([@b30-co-1-267]). Although disturbances of vision and eye movements are recognized as important for making the diagnosis of MS, the neuro-ophthalmologic examination also provides insights into the nature of the disorder in any patient and even in estimating prognosis ([@b22-co-1-267]). Here we review four aspects of the role of eye movements in MS: (1) the value of clinical examination of eye movements in making the diagnosis and estimating the prognosis in MS; (2) how measurement of eye movements may contribute to the diagnosis of MS; (3) how eye movements can be used as an experimental tool to investigate the visual disturbance due to optic neuritis; and (4) current concepts of treatment of acquired forms of nystagmus due to MS and their visual consequences.

Clinical examination of eye movements
=====================================

A systematic examination of eye movements in patients with MS shows a range of disorders ([Table 1](#t1-co-1-267){ref-type="table"}). The most common eye movement abnormalities are saccadic dysmetria, internuclear ophthalmoplegia (INO), disorders of the vestibulo-ocular reflex (VOR), and gaze-evoked nystagmus ([@b18-co-1-267]; [@b44-co-1-267]; [@b17-co-1-267]). Saccades are the rapid, brief eye movements by which we shift the point of fixation from one feature of interest to the next. Normal subjects show mild undershoots (hypometria), especially for larger saccades; however, with repetitive saccades, the eye lands on the visual target. Patients with MS may show persistent dysmetria, including overshoots (hypermetria) and directional dysmetria (eg, an inappropriate vertical component during a horizontal saccade, requiring a vertical corrective movement). In normal subjects, saccades of each eye are conjugate vertically, but are mildly disjunctive horizontally, with the abducting eye initially leading (producing transient divergence) and the adducting eye eventually catching up (causing transient convergence) ([@b12-co-1-267]). This minor, transient disconjugacy of horizontal saccades in normal subjects cannot be discerned at the bedside. However, in INO, the adducting movement is visibly slowed (adduction lag) compared with the abducting movement. Slowing of adduction occurs because the pulse of innervation that causes rapid contraction of the medial rectus muscle is deficient, since the demyelinated axons of the medial longitudinal fasciculus (MLF) cannot conduct the high-frequency discharge ([@b30-co-1-267]). In classic INO, the findings include restricted adduction and adduction lag in the eye ipsilateral to the MLF lesion and dissociated abducting "nystagmus" of the contralateral eye (which is discussed in the last section). Milder forms of INO cause adduction lag but no restriction of adduction or abducting "nystagmus" ([@b13-co-1-267]; [@b38-co-1-267]). This adduction lag is most easily visualized with rapid eye movements; thus, INO is best detected by testing saccades, and may be missed if only pursuit movements are examined ("follow my finger").

The VOR is most conveniently tested at the bedside using the head impulse test: a small but rapid head turn is evoked by the examiner while the patient views a stationary far visual target ([@b25-co-1-267]). An inadequate vestibular response is evidenced by a corrective saccade at the end of the head rotation. In patients with INO, the horizontal VOR may be impaired in the adducting eye. With vertical head rotations, an asymmetry of upward versus downward head rotations may be evident since the VOR to upward head rotations depends more on the MLF than in response to downward head rotations. Patients with acute INO may also develop a skew deviation, the eye being higher on the side of the lesion. Furthermore, some MS patients show deviation of the subjective visual vertical, assessed with a simple laser pointer fitted with inexpensive line-generating optics ([@b44-co-1-267]), or a Maddox rod.

Carefully conducted clinical studies have established that patients who have abnormal eye movements are more disabled than those with normal motility, and that this difference is sustained after two years ([@b18-co-1-267]; [@b44-co-1-267]; [@b17-co-1-267]). The reason for the increased disability in MS patients with abnormal eye movements is less due to their impaired vision than to their disturbance of gait. In such patients, MRI scans confirm that both abnormal eye movements and gait disturbance are caused by prominent involvement of the brainstem and cerebellar pathways.

Measuring eye movements to aid diagnosis of MS
==============================================

Clinical detection of INO and saccadic abnormalities in MS may be challenging ([@b23-co-1-267]), and measurement of eye movements may help confirm the diagnosis during early stages of the disease. A representative example is shown in [Figure 1](#f1-co-1-267){ref-type="fig"}.

Detection of a saccadic abnormality may be better when targets are presented randomly, so that neither their time of onset nor their location can be predicted. Large saccades (20 degrees or greater) are more likely to show changes in velocity than are small saccades. In making paired comparison of the peak velocity of abducting and adducting saccades, it is important to take account of the fact that normal subjects show somewhat greater peak velocities in the abducting eye, depending on the methodology being used ([@b12-co-1-267]). A more reliable approach is to measure the ratio of abducting/adducting movements during horizontal saccades, and compare the patient's value with that of group of normal subjects recorded in the same laboratory ([@b20-co-1-267]; [@b21-co-1-267]; [@b23-co-1-267]). Patients with INO have abduction/adduction ratios for peak velocity or peak acceleration that lie outside the 95% prediction intervals for normal subjects. Another approach is to plot eye velocity versus eye displacement (position) for each eye -- phase plane plots. Normal subjects show very similar initial phase-plane plots for each eye whereas in INO, the plots of each eye deviate at the start of the movement.

Other saccadic abnormalities in multiple sclerosis include increased reaction time (latency), inaccuracy (dysmetria), and decreased velocity ([@b41-co-1-267]; [@b11-co-1-267]; [@b35-co-1-267]). Some patients with MS show saccadic oscillations or unwanted saccades that intrude on steady fixation or smooth pursuit ([@b26-co-1-267]; [@b2-co-1-267]; [@b43-co-1-267]).

Smooth-pursuit tracking may be impaired (reduced gain) ([@b45-co-1-267]; [@b41-co-1-267]), and there may be impaired cancellation of the horizontal vestibulo-ocular reflex (VOR) when patients attend to a head-fixed target during rotation in a chair ([@b45-co-1-267]). Unilateral internuclear ophthalmoplegia may impair asymmetrically the vertical vestibulo-ocular reflex during stimulation of the contralateral posterior semicircular canal, which depends on the medial longitudinal fasciculus for normal responses ([@b14-co-1-267]). Bilateral internuclear ophthalmoplegia impairs the vertical vestibulo-ocular reflex, gaze holding, smooth pursuit, and eye-head tracking -- all functions that also depend on the medial longitudinal fasciculus ([@b40-co-1-267]). Patients with head tremor and an impaired vestibulo-ocular reflex may report oscillopsia -- illusory motion of the visual world ([@b39-co-1-267]).

Less commonly, MS may cause horizontal and vertical gaze palsies ([@b52-co-1-267]; [@b33-co-1-267]; [@b49-co-1-267]; [@b36-co-1-267]), or individual oculomotor, trochlear or abducens palsies due to brainstem plaques ([@b30-co-1-267]), upbeat and downbeat nystagmus ([@b19-co-1-267]; [@b34-co-1-267]; [@b7-co-1-267]), and a range of vestibular and optokinetic abnormalities ([@b28-co-1-267]; [@b27-co-1-267]; [@b50-co-1-267]). MRI often aids identification of brainstem or cerebellar lesions responsible for such abnormalities; thin cuts and proton density images may be required.

Diagnosis of multiple sclerosis depends on demonstration of lesions disseminated throughout the nervous system ([@b22-co-1-267]). Early diagnosis has become more important because prompt initiation of immunotherapy has the best chance of arresting the disease. Although detection of subtle deficits of ocular motility, such as INO, may be useful in making a diagnosis, some caution is required since these tests are not specific for multiple sclerosis. Thus, the clinician must weigh the results of ocular motor studies with other clinical or laboratory findings before making a diagnosis in the context of current criteria ([@b15-co-1-267]). Routine examination of eye movements during follow-up visits to the MS clinic (along with careful evaluation of vision) may provide a useful method of evaluating progress and prognosis. As noted above, patients who are more generally disabled are more likely to develop abnormalities of eye movements, probably because the brunt of the disease is affecting brainstem and cerebellar connections ([@b18-co-1-267]; [@b44-co-1-267]; [@b17-co-1-267]).

Application of eye movements to investigate visual disorders in MS
==================================================================

The signature disturbance of vision in MS is optic neuritis, which typically presents as monocular loss of central vision, accompanied by discomfort with eye movements ([@b22-co-1-267]). Thanks to the longitudinal Optic Neuritis Treatment study, we now have a more detailed knowledge of the clinical characteristics and course of the syndrome, in which over 95% of patients recover 20/40 or better vision by 12 months after the onset of symptoms ([@b10-co-1-267]; [@b3-co-1-267]).

Some patients who suffer optic neuritis make a good recovery of vision as tested by high-contrast Snellen optotypes but show residual visual impairment, particularly with contrast sensitivity and with low-contrast optotypes such as Sloan letters ([@b6-co-1-267]). Color vision may also be asymmetrically impaired in such patients.

We recently investigated whether motion vision could remain compromised after recovery from optic neuritis in a 42-year-old man with MS ([@b42-co-1-267]). Three years after left optic neuritis had reduced his vision to counting fingers, his visual acuity had improved to 20/40 OS (20/20 OD) with Snellen letters but remained at 20/200 OS (20/32 OD) with Sloan letters at 10% contrast. Color vision was normal OD but essentially absent OS. Despite this improvement, he reported subjective visual difficulties OS, which he noted while he was in motion. Rather than perform a subjective test of motion vision, we measured his ocular following response (OFR). The OFR is a measure of first-order, luminance driven motion vision which consists of a sudden conjugate eye movement elicited at ultra-short latencies by rapid shift of a large visual stimulus ([@b46-co-1-267]). One advantage of studying motion vision by measuring the short-latency OFR is that this eye-tracking response is rather automatic and not substantially influenced by the level of attentiveness of the subject. The stimuli we applied consisted of ¼-cycle shifts of a sine-wave grating with a spatial frequency of either 0.153 or 0.458 cycles/degree. We found that his responses to the higher spatial frequency stimulus were impaired in the affected left eye, suggesting predominant post-optic neuritis involvement of parvocellular visual function ([Figure 2](#f2-co-1-267){ref-type="fig"}). Responses to the low spatial frequency stimulus were similar between the two eyes and to controls, suggesting preservation of the magnocellular visual function, which may function as a visual field-holding reflex ([@b37-co-1-267]). Although OFR has been applied to patients with cortical disturbances of vision, this preliminary study suggests that OFR may be a valuable, objective means of further study of visual dysfunction following optic neuritis.

Acquired nystagmus in MS and treatment of its visual consequences
=================================================================

Several forms of nystagmus occur in MS. So-called dissociated nystagmus with INO is more correctly classified as a disorder of saccadic metrics: the adducting eye fails to get on target, and the brain then programs a series of corrective saccades that are not evident in the paretic, adducting eye, but are observed in the abducting eye ([@b30-co-1-267]). Patching the affected eye in unilateral INO for several days reduces "dissociated nystagmus" while patching the normal eye increases it, indicating that plastic-adaptive mechanisms contribute to the nystagmus ([@b53-co-1-267]).

Although upbeat, downbeat, and seesaw nystagmus all may occur in MS, it is acquired pendular nystagmus (APN) that is most visually disabling. APN is also a feature of other disorders of central myelin, including Pelizaeus-Merzbacher disease ([@b51-co-1-267]), peroxisomal assembly disorders ([@b29-co-1-267]), and in toluene abuse ([@b32-co-1-267]). Since patients with MS who have pendular nystagmus often also have evidence of optic nerve demyelination, it follows that prolonged response time of the visual processing might be responsible for the ocular oscillations. Support for this hypothesis comes from the observation that oscillations are usually larger in the eye with evidence of more severe optic nerve demyelination ([@b9-co-1-267]). However, the nystagmus often remains unchanged in darkness (when visual inputs have no influence on eye movements). Furthermore, spontaneous ocular oscillations can be induced in normal subjects by experimentally delaying the latency of visual feedback during fixation; however, the frequency of these induced oscillations is less than 2 Hz, which is lower than in most patients with pendular nystagmus due to multiple sclerosis ([@b5-co-1-267]). Furthermore, when this experimental technique was applied to patients with acquired pendular nystagmus, it did not change the characteristics of the nystagmus, but instead superimposed lower-frequency oscillations similar to those induced in normal subjects ([@b5-co-1-267]). Thus, disturbance of visual fixation due to visual delays cannot wholly account for the high-frequency oscillations that often characterize acquired pendular nystagmus.

An important observation concerning acquired pendular nystagmus in multiple sclerosis is that some patients show transient suppression of their oscillations following a saccade ([Figure 3](#f3-co-1-267){ref-type="fig"}). Systematic comparison of the oscillations prior to, and following, a saccade has demonstrated that the oscillations are phase-shifted (reset) leading to the hypothesis that the oscillations of APN in patients with multiple sclerosis arise in the neural integrator for eye movements, and that large saccades affect the timing of the oscillations by "resetting" the integrator with the large pulse of neural activity ([@b16-co-1-267]). The nucleus prepositus hypoglossi and medial vestibular nucleus are important components of the neural integrator, which is probably affected by feedback of signals via cell groups of the paramedian tracts (PMT) to the cerebellar flocculus ([@b30-co-1-267]). Patients with APN show a preponderance of multiple sclerosis plaques in their paramedian pons in the region of the PMT cell groups ([@b31-co-1-267]). Thus, it is postulated that the neural integrator loses normal feedback, becomes unstable, and begins to oscillate, causing acquired pendular nystagmus. The neurotransmitters used by neurons that contribute to normal neural integration of ocular motor signals are know to include glutamate and gabapentin ([@b48-co-1-267]; [@b1-co-1-267]). This has led to clinical trials that have demonstrated gabapentin ([@b4-co-1-267]; [@b8-co-1-267]), and memantine ([@b47-co-1-267]) may ameliorate the visually disabling acquired pendular nystagmus that occurs in multiple sclerosis. Our personal experience is that most patients with APN due to MS visually benefit from either gabapentin or memantine. Both drugs are usually well tolerated, although gabapentin sometimes increases ataxia.

Summary
=======

In the past twenty years, eye movements have moved beyond the bounds of neuro-ophthalmology and are now widely used by neuroscientists, visual scientists, and psychologists, as well as clinicians in several specialties. The popularity of eye movements as an experimental tool arises, in part, because they can be conveniently and accurately measured and analyzed, but also because much is known concerning their neural substrate. It is therefore, no surprise, that eye movements have been commonly applied to better understand the visual and motor disorders in patients with MS. In this review we draw attention to how eye movements can aid diagnosis of MS at the bedside and in the laboratory. In addition, eye movements can be used as an experimental took to better understand the disorders of vision that occur in MS. Finally, better knowledge concerning neuropharmacology has led to effective drug treatments for abnormal eye movements that degrade vision in patients with demyelinating disease.

![Comparison of a rightward saccade made to a 22 degree target jump by a normal subject **(A)** and a patient with MS who has INO **(B)**. Note how the normal subject's eyes move together, with right eye (abduction) velocity being slightly bigger than that of the left eye. In contrast, the MS patient's adducting left eye lags behind the abducting right, and right eye velocity greatly exceeds that of the left. Positive values indicate rightward movements. Note the different axes for position and velocity.](opth-1-267f1){#f1-co-1-267}

![Representative mean right-left velocity profiles of the ocular following responses (OFR) versus time elicited in a patient with MS who had partially recovered from a left optic neuritis. The patient responded to successive ¼-wavelength shifts applied to *1f* stimuli (left column) and *3f* stimuli (right column) of different contrast (contrast of the pattern is shown by encircled numbers superimposed on traces). **A** and **B**: right-eye-viewing sessions (REV). **C** and **D**: left-eye-viewing sessions (LEV). Note the smaller LEV responses to the *3f* stimuli versus *1f* stimuli. Adapted from ([@b42-co-1-267]).](opth-1-267f2){#f2-co-1-267}

![An example of how a large rightward horizontal saccade could reset the phase of acquired pendular nystagmus (APN) in a patient with multiple sclerosis. A sine wave at a similar frequency to the oscillations is shown in dashed gray for reference. Note that before the saccade, the horizontal component of APN and sine wave are about 180 degrees out of phase; after the saccade, this phase difference is greatly reduced (compare positions of vertical dashed lines). The single-position traces are offset to aid clarity of display; positive deflections indicate rightward eye rotations.](opth-1-267f3){#f3-co-1-267}

###### 

Summary of common disorders of ocular motility in MS ([@b18-co-1-267])

  **Abnormal finding**               **Occurrence in MS patients who show abnormal eye movements**
  ---------------------------------- ---------------------------------------------------------------
  Misalignment of visual axes        32% (usually exotropia)
  Gaze-evoked nystagmus              36%
  Nystagmus in central position      18% (pendular; downbeat)
  Saccadic dysmetria                 91% (59% in both planes)
  Internuclear ophthalmoplegia       68% (27% bilateral)
  Smooth pursuit impaired            32%
  Vestibulo-ocular reflex impaired   36%
  Vergence impaired                  23%

**Abbreviation:** VOR, vestibulo-ocular reflex.
